According to the Zhitong Finance App, Sanxin Medical (300453.SZ) announced that the company's holding subsidiary Jiangxi Colectin Biotechnology Co., Ltd. (“colevipid”) has obtained a “Medical Device Production License” issued by the Jiangxi Drug Administration.

The acquisition of the “Medical Device Production License” by Colectin is based on actual production and operation needs. It helps the company promote the production and operation of medical devices related to vascular access and peripheral vascular intervention, improves the company's industrial layout, further enhances the company's market competitiveness, and will have a positive impact on the company's future production and operation.